These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 20682373

  • 1. Potential anticancer properties of bisphosphonates.
    Neville-Webbe HL, Gnant M, Coleman RE.
    Semin Oncol; 2010 Jun; 37 Suppl 1():S53-65. PubMed ID: 20682373
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease.
    Neville-Webbe HL, Coleman RE.
    Eur J Cancer; 2010 May; 46(7):1211-22. PubMed ID: 20347292
    [Abstract] [Full Text] [Related]

  • 3. Bisphosphonates in breast cancer: clinical activity and implications of preclinical data.
    Aft R.
    Clin Adv Hematol Oncol; 2011 Mar; 9(3):194-205. PubMed ID: 21475125
    [Abstract] [Full Text] [Related]

  • 4. Anticancer properties of zoledronic acid.
    Green J, Lipton A.
    Cancer Invest; 2010 Nov; 28(9):944-57. PubMed ID: 20879838
    [Abstract] [Full Text] [Related]

  • 5. Bisphosphonates: preclinical review.
    Green JR.
    Oncologist; 2004 Nov; 9 Suppl 4():3-13. PubMed ID: 15459425
    [Abstract] [Full Text] [Related]

  • 6. Clinical value of bisphosphonates in cancer therapy.
    Lüftner D, Henschke P, Possinger K.
    Anticancer Res; 2007 Nov; 27(4A):1759-68. PubMed ID: 17649770
    [Abstract] [Full Text] [Related]

  • 7. New results from the use of bisphosphonates in cancer patients.
    Coleman R, Gnant M.
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
    [Abstract] [Full Text] [Related]

  • 8. [Antitumour effects of bisphosphonates in breast cancer].
    van de Ven S, Kroep JR, Hamdy NA, Sleeboom HP, Nortier HW.
    Ned Tijdschr Geneeskd; 2010 Sep; 154():A1951. PubMed ID: 21083955
    [Abstract] [Full Text] [Related]

  • 9. Bisphosphonates as anticancer therapy for early breast cancer.
    Mahtani R, Jahanzeb M.
    Clin Breast Cancer; 2010 Oct 01; 10(5):359-66. PubMed ID: 20920980
    [Abstract] [Full Text] [Related]

  • 10. Antitumor effects and anticancer applications of bisphosphonates.
    Morgan G, Lipton A.
    Semin Oncol; 2010 Oct 01; 37 Suppl 2():S30-40. PubMed ID: 21111246
    [Abstract] [Full Text] [Related]

  • 11. The antitumor potential of bisphosphonates.
    Clézardin P.
    Semin Oncol; 2002 Dec 01; 29(6 Suppl 21):33-42. PubMed ID: 12584693
    [Abstract] [Full Text] [Related]

  • 12. Are bisphosphonates the suitable anticancer drugs for the elderly?
    Santini D, Fratto ME, Galluzzo S, Vincenzi B, Tonini G.
    Crit Rev Oncol Hematol; 2009 Jan 01; 69(1):83-94. PubMed ID: 18692400
    [Abstract] [Full Text] [Related]

  • 13. Exploring the anti-tumour activity of bisphosphonates in early breast cancer.
    Winter MC, Holen I, Coleman RE.
    Cancer Treat Rev; 2008 Aug 01; 34(5):453-75. PubMed ID: 18423992
    [Abstract] [Full Text] [Related]

  • 14. Management of castration-resistant prostate cancer: bisphosphonates and emerging therapies.
    Saad F, Colombel M.
    Expert Rev Anticancer Ther; 2010 Dec 01; 10(12):1991-2002. PubMed ID: 21110764
    [Abstract] [Full Text] [Related]

  • 15. Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone.
    Lipton A.
    Cancer Treat Rev; 2008 Dec 01; 34 Suppl 1():S25-30. PubMed ID: 18486347
    [Abstract] [Full Text] [Related]

  • 16. On the horizon: can bisphosphonates prevent bone metastases?
    Coleman R.
    Breast; 2007 Dec 01; 16 Suppl 3():S21-7. PubMed ID: 17988867
    [Abstract] [Full Text] [Related]

  • 17. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ, Mancini I.
    Support Care Cancer; 2002 Jul 01; 10(5):399-407. PubMed ID: 12136223
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity.
    Clézardin P, Ebetino FH, Fournier PG.
    Cancer Res; 2005 Jun 15; 65(12):4971-4. PubMed ID: 15958534
    [Abstract] [Full Text] [Related]

  • 19. Bisphosphonates for the prevention of bone metastases.
    Coleman RE.
    Semin Oncol; 2002 Dec 15; 29(6 Suppl 21):43-9. PubMed ID: 12584694
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.